Estrogen impact on the genetic response to interferon therapy in HCV patients / Radwa Yehia Mekky ; Suprevised Ahmed Ihab Abdelaziz , Nabila Hamdi
Material type:
Item type | Current library | Home library | Call number | Status | Barcode | |
---|---|---|---|---|---|---|
![]() |
قاعة الثقاقات الاجنبية - الدور الثالث | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.34.M.Sc.2010.Ra.E (Browse shelf(Opens below)) | Not for loan | 01010110072225000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Garman University - Faculty of Postgraduate Studies and Scientific Research - Department of Molecular Genetics
Chronic hepatitis C infection is considered one of the major threats worldwide, with high prevalence in Africa and Middle East especially in Egypt. The current standard treatment of choice of HCV infection consists of a weekly subcutanrous administration of pegylated interferon alpha (PEG-IFN) in combination with daily oral doses of ribavirin.
There are no comments on this title.